Akèy › Gliyoblastòm › Virginia
Etid klinik pou Gliyoblastòm nan Virginia
10 etid pou Gliyoblastòm ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
Tèks ofisyèl etid la (Anglè)
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Virginia Health, Charlottesville
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT03970447Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07195591VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Inova Schar Cancer, Fairfax
Ap rekriteFaz 2
Laj 18 a 98 · Tout sèks · Mizajou Sep 21, 2026 · NCT07831369FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06989086SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
- Inova Schar Cancer Institute, Fairfax
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
- University of Virginia, Charlottesville
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou May 6, 2026 · NCT07343986Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Apr 28, 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.